Hyperlipidemia in hemodialysis patients
Nishikawa, O.; Mune, M.; Yukawa, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 753-757
2001
ISSN/ISBN: 0047-1852 PMID: 11347168 Document Number: 526555
Document emailed within 1 workday
Related Documents
Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187Fujii, N. 2018: Bone and Mineral Metabolism in Hemodialysis Patients. Fragility Fractures in Hemodialysis Patients Clinical Calcium 28(8): 1037-1044
Tanaka, H.; Nishikawa, O.; Yukawa, S.; Yoshimoto, M.; Nishide, I. 1999: Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients Nihon Jinzo Gakkai Shi 41(1): 1-7
Caban, M.; Smoleński, O.; Barylak, H.; Kutrzeba, W. 1977: Effect of hemodialysis on the ATP blood level in patients with chronic kidney failure treated with hemodialysis Polski Tygodnik Lekarski 32(35): 1369
Prejac, M.; Mikulicic, V.; Jeren-Struić, B.; Kozjak, D. 1980: The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen Lijecnicki Vjesnik 102(7-8): 386-391
Yuan, J.; Zha, Y.; Yang, X.; He, S.; Xie, Y.; Huang, R.-s.; Xiong, H.-y.; Sun, Z.-l. 2013: Effects of distance between residence and hemodialysis unit on cardiovascular complications and treatments of maintenance hemodialysis patients Zhonghua Yi Xue Za Zhi 93(22): 1734-1736
Uetake, S.; Takahashi, M.; Tamano, K.; Honda, T.; Kobayashi, T.; Horinaka, S. 2001: Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction Journal of Cardiology 38(2): 61-71
Docci, D.; Bilancioni, R.; Turci, F.; Baldrati, L. 1985: Hyperlipidemia in uremic patients in dialysis Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 21(4): 424-429
Umeda, T.; Sato, T.; Hamasaki, S.; Fujimoto, Y. 1992: Antihypertensive therapy of the patients with hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 211-217
Válek, J.; Grafnetter, D.; Slabochová, Z.; Platilová, H. 1975: Hyperlipidemia and hyperlipoproteinemia among the relatives of diabetic patients Casopis Lekaru Ceskych 114(27): 837-840
Nikitina, N.M.; Rebrov, A.P. 2009: The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia Kardiologiia 49(9): 21-26
Vílchez Joya, R.; Escobar Jiménez, F.; Campos, M.M.; Torres, E.; Orduña, R.; Cabrera, J.; Núñez, J. 1986: Effects of bezafibrate in patients with combined hyperlipidemia Medicina Clinica 86(5): 190-194
Hegele, R.A.; Connelly, P.W.; Maguire, G.F.; Huff, M.W.; Leiter, L.; Wolfe, B.M.; Evans, A.J.; Little, J.A. 1991: An apolipoprotein CIi mutation, CIILys19----Thr' identified in patients with hyperlipidemia Disease Markers 9(2): 73-80
Okopień, B.ła.; Cwalina, Łu.; Haberka, M.; Kowalski, J.; Zieliński, M.; Szwed, Z.; Kalina, Z.; Herman, Z.S. 2002: Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(78): 465-469
Larsen, M.L.; Laursen, S.O.; Hansen, A.B.; Blaabjerg, O.; Nielsen, B.L.; Hørder, M. 1989: Diagnosis of hyperlipidemia in patients admitted with acute myocardial infarction Ugeskrift for Laeger 151(8): 487-489
Panchenko, V.M.; Ershov, A.A.; Isaev, V.A.; ZImovchenko, G.S.; Chernova, G.I. 2001: Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus Klinicheskaia Meditsina 79(6): 47-49
Knight, R.J.; Vathsala, A.; Schoenberg, L.; Camel, S.; Weinberg, R.B.; Goldstein, R.A.; Lewis, R.M.; van Buren, C.T.; Kahan, B.D. 1992: Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification Transplantation 53(1): 224-225
Martina, B.; Weinbacher, M.; Kiener, S.; Keller, U.; Battegay, E. 1996: Reproducibility of fasting serum cholesterol and triglycerides in ambulatory patients with mixed hyperlipidemia Schweizerische Medizinische Wochenschrift 126(50): 2175-2180
Noseda, G.; Suvà, F.; Fragiacomo, C. 1985: Modification of serum lipids, lipoproteins and apoproteins Ai and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine Schweizerische Medizinische Wochenschrift 115(30): 1064-1070
Brath, H.; Wascher, T.C.; Kästenbauer, T.; Toplak, H. 2012: Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances MMW Fortschritte der Medizin 154(Suppl 2): 41-47